180 related articles for article (PubMed ID: 27473611)
1. Ca
Zhong W; Picca AJ; Lee AS; Darmani NA
Auton Neurosci; 2017 Jan; 202():18-27. PubMed ID: 27473611
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva).
Darmani NA; Zhong W; Chebolu S; Vaezi M; Alkam T
Eur J Pharmacol; 2014 Jan; 722():2-12. PubMed ID: 24513517
[TBL] [Abstract][Full Text] [Related]
3. Thapsigargin-induced activation of Ca(2+)-CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew.
Zhong W; Chebolu S; Darmani NA
Neuropharmacology; 2016 Apr; 103():195-210. PubMed ID: 26631534
[TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum antiemetic efficacy of the L-type calcium channel blocker amlodipine in the least shrew (Cryptotis parva).
Zhong W; Chebolu S; Darmani NA
Pharmacol Biochem Behav; 2014 May; 120():124-32. PubMed ID: 24631485
[TBL] [Abstract][Full Text] [Related]
5. Intracellular emetic signaling evoked by the L-type Ca
Zhong W; Chebolu S; Darmani NA
Eur J Pharmacol; 2018 Sep; 834():157-168. PubMed ID: 29966616
[TBL] [Abstract][Full Text] [Related]
6. L-type calcium channels contribute to 5-HT3-receptor-evoked CaMKIIα and ERK activation and induction of emesis in the least shrew (Cryptotis parva).
Hutchinson TE; Zhong W; Chebolu S; Wilson SM; Darmani NA
Eur J Pharmacol; 2015 May; 755():110-8. PubMed ID: 25748600
[TBL] [Abstract][Full Text] [Related]
7. Differential and additive suppressive effects of 5-HT3 (palonosetron)- and NK1 (netupitant)-receptor antagonists on cisplatin-induced vomiting and ERK1/2, PKA and PKC activation.
Darmani NA; Zhong W; Chebolu S; Mercadante F
Pharmacol Biochem Behav; 2015 Apr; 131():104-11. PubMed ID: 25687374
[TBL] [Abstract][Full Text] [Related]
8. The anti-asthmatic drug pranlukast suppresses the delayed-phase vomiting and reverses intracellular indices of emesis evoked by cisplatin in the least shrew (Cryptotis parva).
Darmani NA; Chebolu S; Zhong W; Kim WD; Narlesky M; Adams J; Dong F
Eur J Pharmacol; 2017 Aug; 809():20-31. PubMed ID: 28501575
[TBL] [Abstract][Full Text] [Related]
9. Evidence for Bell-Shaped Dose-Response Emetic Effects of Temsirolimus and Analogs: The Broad-Spectrum Antiemetic Efficacy of a Large Dose of Temsirolimus Against Diverse Emetogens in the Least Shrew (
Belkacemi L; Sun Y; Darmani NA
Front Pharmacol; 2022; 13():848673. PubMed ID: 35444553
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva).
Darmani NA; Chebolu S; Amos B; Alkam T
Pharmacol Biochem Behav; 2011 Oct; 99(4):573-9. PubMed ID: 21683089
[TBL] [Abstract][Full Text] [Related]
11. The Contribution of Phospholipase C in Vomiting in the Least Shrew (Cryptotis Parva) Model of Emesis.
Zhong W; Darmani NA
Front Pharmacol; 2021; 12():736842. PubMed ID: 34566660
[TBL] [Abstract][Full Text] [Related]
12. Ultra-low doses of the transient receptor potential vanilloid 1 agonist, resiniferatoxin, prevents vomiting evoked by diverse emetogens in the least shrew (Cryptotis parva).
Darmani NA; Henry DA; Zhong W; Chebolu S
Behav Pharmacol; 2020 Feb; 31(1):3-14. PubMed ID: 31503071
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis.
Rojas C; Raje M; Tsukamoto T; Slusher BS
Eur J Pharmacol; 2014 Jan; 722():26-37. PubMed ID: 24184669
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting.
Darmani NA
Pharmaceuticals (Basel); 2010 Sep; 3(9):2930-2955. PubMed ID: 27713384
[TBL] [Abstract][Full Text] [Related]
15. Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew).
Rudd JA; Ngan MP; Lu Z; Higgins GA; Giuliano C; Lovati E; Pietra C
Front Pharmacol; 2016; 7():263. PubMed ID: 27630563
[TBL] [Abstract][Full Text] [Related]
16. The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).
Zhong W; Darmani NA
Neurochem Int; 2020 Jan; 132():104603. PubMed ID: 31738972
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron).
Rojas C; Slusher BS
Cancer Treat Rev; 2015 Dec; 41(10):904-13. PubMed ID: 26442475
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-HT3 receptor-mediated vomiting occurs via the activation of Ca2+/CaMKII-dependent ERK1/2 signaling in the least shrew (Cryptotis parva).
Zhong W; Hutchinson TE; Chebolu S; Darmani NA
PLoS One; 2014; 9(8):e104718. PubMed ID: 25121483
[TBL] [Abstract][Full Text] [Related]
19. Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting.
Lorusso V; Karthaus M; Aapro M
Future Oncol; 2015; 11(4):565-77. PubMed ID: 25360998
[TBL] [Abstract][Full Text] [Related]
20. Δ
Darmani NA; Belkacemi L; Zhong W
Eur J Pharmacol; 2019 Dec; 865():172806. PubMed ID: 31738934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
